Breaking News Instant updates and real-time market news.

CHRS

Coherus Biosciences

$22.76

-0.61 (-2.61%)

09:32
07/08/19
07/08
09:32
07/08/19
09:32

Coherus Biosciences sees Q2 preliminary UDENYCA net sales $79M-$84M

Coherus BioSciences announced that UDENYCA preliminary unaudited net sales for the quarter that ended June 30 are expected to be in the range of $79M-$84M. Coherus will not disclose topline gross sales, discounts, or gross-to-net data until these data are reported in its Form 10-Q for the quarter ended June 30.

  • 10

    Jul

CHRS Coherus Biosciences
$22.76

-0.61 (-2.61%)

08/28/18
HCWC
08/28/18
INITIATION
Target $28
HCWC
Buy
Coherus Biosciences initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Jason Kolbert started Coherus Biosciences (CHRS) with a Buy rating and $28 price target. The analyst expects approval of the company's Udencya in both the U.S. and Europe this year. His confidence level is driven by a positive recommendation from the European Committee for Medicinal Products for Human Use in July for marketing authorization of Udencya, a biosimilar compound targeting febrile neutropenia. Coherus announced that the committee reviewed all the new immunogenicity data that were required for the U.S. re-submission too, so the EU recommendation for approval adds a measure of confidence in support of U.S. approval, Kolbert tells investors in a research note. A year-end approval should position Udencya as the second biosimilar in the $4B U.S. marketplace behind Mylan (MYL), which should be launching its product following approval in June, the analyst adds.
05/07/19
HCWC
05/07/19
INITIATION
Target $28
HCWC
Buy
Coherus Biosciences initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Douglas Tsao started Coherus Biosciences with a Buy rating and $28 price target. A fast launch for first product Udenyca, a biosimilar to Amgen's Neulasta, bodes well for long-term value creation, Tsao tells investors in a research note.
06/11/19
LEHM
06/11/19
INITIATION
Target $30
LEHM
Overweight
Coherus Biosciences initiated with an Overweight at Barclays
Barclays analyst Balaji Prasad started Coherus Biosciences with an Overweight rating and $30 price target. The analyst launched coverage of 20 U.S. Specialty Pharmaceuticals with a Neutral industry view. He placed importance on cash flows and companies' ability to manage leverage and improve balance sheets.
06/21/19
LEHM
06/21/19
NO CHANGE
Target $30
LEHM
Overweight
Coherus Biosciences is in 'a league of its own,' says Barclays
After hosting a meeting with management, Barclays analyst Balaji Prasad says Coherus Biosciences is in "a league of its own, having cracked the commercial code." The analyst now has greater confidence in his projected 22% annual Udenyca sales growth through 2023. He expects Udenyca to reach $400M-plus in 2023 and reiterates an Overweight rating on Coherus shares with a $30 price target. The company's additional pipeline opportunities are also underappreciated, Prasad tells investors in a research note.

TODAY'S FREE FLY STORIES

SF

Stifel Financial

$58.67

0.5 (0.86%)

10:03
07/18/19
07/18
10:03
07/18/19
10:03
Hot Stocks
Stifel Financial launches venture banking & lending group »

Stifel Financial Corp.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

10:03
07/18/19
07/18
10:03
07/18/19
10:03
General news
Leading Indicators data reported »

June Leading Indicators…

PPG

PPG

$118.40

1.795 (1.54%)

10:02
07/18/19
07/18
10:02
07/18/19
10:02
Hot Stocks
PPG approves 6% increase in dividend to 51c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 05

    Aug

MDP

Meredith

$53.86

-0.08 (-0.15%)

, NYT

New York Times

$35.11

0.06 (0.17%)

10:01
07/18/19
07/18
10:01
07/18/19
10:01
Hot Stocks
Meredith, New York Times to introduce series of special edition maagazines »

Meredith…

MDP

Meredith

$53.86

-0.08 (-0.15%)

NYT

New York Times

$35.11

0.06 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 13

    Nov

AMK

AssetMark Financial

$0.00

(0.00%)

10:01
07/18/19
07/18
10:01
07/18/19
10:01
Syndicate
Breaking Syndicate news story on AssetMark Financial »

AssetMark Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

PHR

Phreesia

$0.00

(0.00%)

10:00
07/18/19
07/18
10:00
07/18/19
10:00
Syndicate
Breaking Syndicate news story on Phreesia »

Phreesia indicated to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

EBAY

eBay

$41.98

2.95 (7.56%)

, PM

Philip Morris

$85.42

4.36 (5.38%)

09:55
07/18/19
07/18
09:55
07/18/19
09:55
Options
Early notable gainers among liquid option names on July 18th »

Notable gainers among…

EBAY

eBay

$41.98

2.95 (7.56%)

PM

Philip Morris

$85.42

4.36 (5.38%)

UNP

Union Pacific

$172.12

8.07 (4.92%)

IBM

IBM

$145.79

2.72 (1.90%)

KLAC

KLA-Tencor

$129.13

3.55 (2.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 26

    Aug

09:55
07/18/19
07/18
09:55
07/18/19
09:55
General news
Fed's Bullard said an easing now would be insurance against a slowdown »

Fed's Bullard said…

ORCC

Owl Rock

$0.00

(0.00%)

09:52
07/18/19
07/18
09:52
07/18/19
09:52
Syndicate
Breaking Syndicate news story on Owl Rock »

Owl Rock opens at $15.50,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

PHR

Phreesia

$0.00

(0.00%)

09:50
07/18/19
07/18
09:50
07/18/19
09:50
Syndicate
Phreesia indicated to open at $24-$26, IPO priced at $18 »

Phreesia (PHR) priced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

CCI

Crown Castle

$123.87

-7.73 (-5.87%)

09:47
07/18/19
07/18
09:47
07/18/19
09:47
Hot Stocks
Crown Castle falls -5.9% »

Crown Castle is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

SAP

SAP

$126.38

-7.84 (-5.84%)

09:47
07/18/19
07/18
09:47
07/18/19
09:47
Hot Stocks
SAP falls -5.9% »

SAP is down -5.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 01

    Aug

URI

United Rentals

$123.61

-7.94 (-6.04%)

09:47
07/18/19
07/18
09:47
07/18/19
09:47
Hot Stocks
United Rentals falls -5.6% »

United Rentals is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

PM

Philip Morris

$84.80

3.74 (4.61%)

09:47
07/18/19
07/18
09:47
07/18/19
09:47
Hot Stocks
Philip Morris rises 4.8% »

Philip Morris is up 4.8%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

NVS

Novartis

$94.73

4.62 (5.13%)

09:47
07/18/19
07/18
09:47
07/18/19
09:47
Hot Stocks
Novartis rises 5.1% »

Novartis is up 5.1%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 22

    Jul

  • 23

    Jul

  • 25

    Sep

UNP

Union Pacific

$172.62

8.57 (5.22%)

09:47
07/18/19
07/18
09:47
07/18/19
09:47
Hot Stocks
Union Pacific rises 4.9% »

Union Pacific is up 4.9%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 26

    Aug

TMUS

T-Mobile

$78.70

-0.23 (-0.29%)

, S

Sprint

$7.09

-0.01 (-0.14%)

09:46
07/18/19
07/18
09:46
07/18/19
09:46
Periodicals
Next week will bring decision on T-Mobile, Sprint deal, CNBC reports »

The parties involved in…

TMUS

T-Mobile

$78.70

-0.23 (-0.29%)

S

Sprint

$7.09

-0.01 (-0.14%)

DISH

Dish

$40.60

-0.26 (-0.64%)

DTEGY

Deutsche Telekom

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

AEO

American Eagle

$18.10

(0.00%)

, ANF

Abercrombie & Fitch

$18.52

(0.00%)

09:45
07/18/19
07/18
09:45
07/18/19
09:45
Periodicals
American Eagle to offer buy-now, pay-later services, Business Insider reports »

Retailer American Eagle…

AEO

American Eagle

$18.10

(0.00%)

ANF

Abercrombie & Fitch

$18.52

(0.00%)

URBN

Urban Outfitters

$23.26

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 25

    Sep

09:45
07/18/19
07/18
09:45
07/18/19
09:45
General news
Leading Indicators to be reported at 10:00 »

June Leading Indicators…

ORCC

Owl Rock

$0.00

(0.00%)

09:44
07/18/19
07/18
09:44
07/18/19
09:44
Syndicate
Breaking Syndicate news story on Owl Rock »

Owl Rock indicated to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

AMK

AssetMark Financial

$0.00

(0.00%)

09:44
07/18/19
07/18
09:44
07/18/19
09:44
Syndicate
Breaking Syndicate news story on AssetMark Financial »

AssetMark Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

DTEGY

Deutsche Telekom

$0.00

(0.00%)

, S

Sprint

$7.10

(0.00%)

09:42
07/18/19
07/18
09:42
07/18/19
09:42
Periodicals
Breaking Periodicals news story on Deutsche Telekom, Sprint, T-Mobile, Dish »

Deutsche Telekom needs to…

DTEGY

Deutsche Telekom

$0.00

(0.00%)

S

Sprint

$7.10

(0.00%)

TMUS

T-Mobile

$78.93

(0.00%)

DISH

Dish

$40.86

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

TMUS

T-Mobile

$78.93

(0.00%)

, S

Sprint

$7.10

(0.00%)

09:41
07/18/19
07/18
09:41
07/18/19
09:41
Periodicals
Breaking Periodicals news story on T-Mobile, Sprint, Dish »

T-Mobile, Sprint, Dish…

TMUS

T-Mobile

$78.93

(0.00%)

S

Sprint

$7.10

(0.00%)

DISH

Dish

$40.86

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

TMUS

T-Mobile

$78.93

-0.11 (-0.14%)

, S

Sprint

$7.10

(0.00%)

09:40
07/18/19
07/18
09:40
07/18/19
09:40
Periodicals
Breaking Periodicals news story on T-Mobile, Sprint »

Control of Dish wireless…

TMUS

T-Mobile

$78.93

-0.11 (-0.14%)

S

Sprint

$7.10

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

ENPH

Enphase Energy

$20.19

(0.00%)

, EBAY

eBay

$39.03

(0.00%)

09:40
07/18/19
07/18
09:40
07/18/19
09:40
Options
Unusually active option classes on open July 18th »

Unusual total active…

ENPH

Enphase Energy

$20.19

(0.00%)

EBAY

eBay

$39.03

(0.00%)

URI

United Rentals

$131.55

(0.00%)

IBM

IBM

$143.07

(0.00%)

CLDR

Cloudera

$5.48

(0.00%)

UNH

UnitedHealth

$266.71

(0.00%)

KMI

Kinder Morgan

$20.60

(0.00%)

NOK

Nokia

$5.17

(0.00%)

GDXJ

VanEck Vectors Junior Gold Miners

$37.66

(0.00%)

PM

Philip Morris

$81.06

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 25

    Jul

  • 30

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.